Conduit Pharmaceuticals Inc.

NASDAQ (USD): Conduit Pharmaceuticals Inc. (CDT)

Last Price

0.094

Today's Change

+0.004 (4.44%)

Day's Change

0.087 - 0.096

Trading Volume

4,902,774

Profile
CDT

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. David Joszef Tapolczay Dr. David Joszef Tapolczay

Full Time Employees:  7 7

IPO Date:  2022-03-28 2022-03-28

CIK:  0001896212 0001896212

ISIN:  US20678X1063 US20678X1063

CUSIP:  20678X106 20678X106

Beta:  2.12 2.12

Last Dividend:  0.00 0.00

Dcf Diff:  0.05 0.05

Dcf:  0.05 0.05

Description

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Address

4995 Murphy Canyon Road,
San Diego, CA 92134, US

760 471 8536

http://www.conduitpharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment